Monday - May 5, 2025

LOGIN  |  REGISTER
Recursion
Amneal Pharmaceuticals

Brookdale Senior Living Reports August 2023 Occupancy

September 11, 2023 | Last Trade: US$6.66 0.08 1.22

NASHVILLE, Tenn., Sept. 11, 2023 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for August 2023.

Brookdale’s Consolidated Occupancy

August 2023 Observations:

  • Achieved more than 2,200 move-ins during August, the highest number of move-ins over the past five years.
  • August 2023 weighted average occupancy increased 50 basis points sequentially, from 77.1% in July 2023 to 77.6% in August 2023.
  • Supported by a 120 basis point increase over 2022, August represented 22 consecutive months of year-over-year weighted average occupancy growth.
  • August month end occupancy surpassed 79.0% and achieved new high since the start of the recovery in March 2021.

About Brookdale Senior Living

Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, and stay connected with friends and loved ones. Brookdale, through its affiliates, operates and manages 672 communities in 41 states as of June 30, 2023, with the ability to serve more than 60,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.

 

C4 Therapeutics

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page